INNATE PHARMA (EPA:IPH) U.S. Food and Drug Administration lifts partial clinical hold on lacutamab TELLOMAK trial in advanced T-cell lymphomas
Transparency directive : regulatory news
24/06/2020 07:00
INNATE PHARMA's latest news
05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00
26/04/2023 22:50
21/04/2023 07:00
Other stories
16/05/2024 19:26
16/05/2024 14:36
16/05/2024 15:26
16/05/2024 14:37
16/05/2024 12:00
16/05/2024 13:32
16/05/2024 19:17
16/05/2024 18:42
16/05/2024 15:35
16/05/2024 18:03
16/05/2024 17:52
16/05/2024 19:00
16/05/2024 15:05
16/05/2024 12:35
16/05/2024 16:47
16/05/2024 15:29
16/05/2024 13:10
16/05/2024 13:37
16/05/2024 16:07
16/05/2024 12:22
16/05/2024 08:00
16/05/2024 00:56
16/05/2024 18:00
16/05/2024 06:00
16/05/2024 16:52
15/05/2024 21:30
16/05/2024 17:38
16/05/2024 14:41
16/05/2024 16:33
16/05/2024 14:22
15/05/2024 22:40
16/05/2024 18:19
15/05/2024 11:19
16/05/2024 09:24
16/05/2024 10:02
16/05/2024 15:24
16/05/2024 10:15
15/05/2024 19:40